Skip to main content
Erschienen in: International Urology and Nephrology 3/2011

01.09.2011 | Nephrology – Original Paper

The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic

verfasst von: Joseph B. Davies, Martin A. Crook, Anthony S. Wierzbicki, David J. Goldsmith

Erschienen in: International Urology and Nephrology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The prevalence of chronic kidney disease (CKD) stages 3 to 5, defined as eGFR <60 ml/min/1.73 m2 for more than three months, in the United Kingdom (UK) is 8%. We investigated the incidence of low eGFR and proteinuria in patients attending our large tertiary referral lipid clinic in 2008.

Methods

In 2008, 1,283 patients were seen, of which 1,029 had complete serum lipid and renal profiles. Estimated glomerular filtration rate (eGFR) was calculated for these patients using the 4-variable MDRD formula. The prevalence of low eGFR (eGFR < 60 ml/min/1.73 m2) and proteinuria (albumin/creatinine ratio >2.4 mg/mmol or urinary protein excretion >0.06 g/l) was calculated.

Results

The prevalence of low eGFR and proteinuria was 11.2 and 19.4%, respectively. The percentage of patients with serum lipid levels within the target range suggested by international guidelines was lower among those with low eGFR and proteinuria than in the entire study population, despite similar proportions being treated with statins across all groups.

Conclusions

The prevalences of low eGFR and proteinuria in a group of 1,029 dyslipidaemic patients attending a large tertiary referral lipid clinic were 11.18 and 19.42%, respectively. These levels are much higher than in the general UK population.
Literatur
1.
Zurück zum Zitat K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266 K/DOQI (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
2.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047PubMedCrossRef Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047PubMedCrossRef
3.
Zurück zum Zitat National Collaborating Centre for Chronic Conditions (2008) Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary care and secondary care. National Institute for Health and Clinical Excellence Clinical guideline 73, London, UK National Collaborating Centre for Chronic Conditions (2008) Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary care and secondary care. National Institute for Health and Clinical Excellence Clinical guideline 73, London, UK
4.
Zurück zum Zitat Schaeffner E, Kurth T, Curhan G et al (2003) Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14(8):2084–2091PubMed Schaeffner E, Kurth T, Curhan G et al (2003) Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14(8):2084–2091PubMed
5.
Zurück zum Zitat Caldicott Committee (1997) Report on the review of patient identifiable information. Department of Health, London UK Caldicott Committee (1997) Report on the review of patient identifiable information. Department of Health, London UK
7.
Zurück zum Zitat Levey A, Coresh J, Greene T et al (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53(4):766–772PubMedCrossRef Levey A, Coresh J, Greene T et al (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53(4):766–772PubMedCrossRef
8.
Zurück zum Zitat Blaustein D, Kumar R, Goyzueta J (1995) Isolated proteinuria: diagnosis and evaluation. Prim Care Update Ob Gyns 2(6):204–206CrossRef Blaustein D, Kumar R, Goyzueta J (1995) Isolated proteinuria: diagnosis and evaluation. Prim Care Update Ob Gyns 2(6):204–206CrossRef
9.
Zurück zum Zitat Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circ 106: 3143 Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circ 106: 3143
10.
Zurück zum Zitat Samuelsson O, Mulec H, Knight-Gibson C et al (1997) Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12(9):1908–1915PubMedCrossRef Samuelsson O, Mulec H, Knight-Gibson C et al (1997) Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12(9):1908–1915PubMedCrossRef
11.
Zurück zum Zitat Muntner P, Coresh J, Smith J et al (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58(1):293–301PubMedCrossRef Muntner P, Coresh J, Smith J et al (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58(1):293–301PubMedCrossRef
12.
Zurück zum Zitat Fox C, Larson M, Leip E et al (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291(7):844–850PubMedCrossRef Fox C, Larson M, Leip E et al (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291(7):844–850PubMedCrossRef
13.
Zurück zum Zitat Manttari M, Tiula E, Alikoski T et al (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26(4):670–675PubMed Manttari M, Tiula E, Alikoski T et al (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26(4):670–675PubMed
14.
Zurück zum Zitat Coresh J (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (in press) Coresh J (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (in press)
15.
Zurück zum Zitat Landray M, Baigent C, Leaper C et al (2006) The second United Kingdom heart and renal protection (UK-HARP-II) study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am J Kidney Dis 47(3):385–395PubMedCrossRef Landray M, Baigent C, Leaper C et al (2006) The second United Kingdom heart and renal protection (UK-HARP-II) study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am J Kidney Dis 47(3):385–395PubMedCrossRef
16.
Zurück zum Zitat Baigent C, Landry M (2003) Study of heart and renal protection (SHARP). Kidney Int Suppl 84:S207–S210PubMedCrossRef Baigent C, Landry M (2003) Study of heart and renal protection (SHARP). Kidney Int Suppl 84:S207–S210PubMedCrossRef
Metadaten
Titel
The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic
verfasst von
Joseph B. Davies
Martin A. Crook
Anthony S. Wierzbicki
David J. Goldsmith
Publikationsdatum
01.09.2011
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2011
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9819-3

Weitere Artikel der Ausgabe 3/2011

International Urology and Nephrology 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.